What is Luminare?
Luminare is dedicated to enhancing healthcare workflows and improving patient outcomes through cutting-edge technology. The company's core offering is a patented patient phenotyping algorithm designed to combat sepsis mortality by integrating seamlessly with existing Electronic Health Record (EHR) systems. This innovative solution aims to bolster detection and treatment efficacy, thereby improving overall patient care. Primarily targeting hospitals and healthcare organizations, Luminare's technology is engineered to drive increased revenue, reduce intensive care unit (ICU) length of stay, and elevate patient safety standards. Their customized approach ensures healthcare providers can optimize resource allocation and ultimately save lives.
How much funding has Luminare raised?
Luminare has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
What's next for Luminare?
With substantial late-stage funding, Luminare is poised for significant expansion and market penetration. The recent strategic investment signals confidence from stakeholders in the company's proven ability to deliver tangible improvements in patient care and operational efficiency for healthcare institutions. This capital infusion will likely fuel further development of their AI-driven phenotyping technology, enhance sales and marketing efforts to reach a broader client base, and potentially explore new applications within the healthcare ecosystem. Luminare's trajectory suggests a continued focus on leveraging technology to solve complex healthcare problems and solidify its position as a leader in patient outcome optimization.
See full Luminare company page
